Who owns Nexelis?
WELLESLEY, MA & Laval, Quebec – January 10, 2022 – Ampersand Capital Partners announced today that its portfolio company Nexelis has been acquired by Q2 Solutions, a leading global clinical trial laboratory services organization, and a wholly owned subsidiary of IQVIA, Inc.
What does Nexelis do?
Combining cutting-edge technology platforms and state-of-the-art laboratories with over 20 years of vaccine testing experience, Nexelis is the immunology partner of choice to support your candidate selection and assay development.
Is Nexelis a CRO?
At Nexelis, a Q² Solutions Company, we built a state-of-the-art CRO, driven by scientific discipline, and aided by our advanced facilities and cutting-edge technology through our global network of specialty laboratories.
What is fit for purpose assay?
The fit-for-purpose approach to biomarker method validation tailors the burden of proof required to validate an assay to take account of both the nature of technology utilised and position of the biomarker in the spectrum between research tool and clinical end point.
What is fit for purpose FDA?
The Fit-for-Purpose (FFP) Initiative provides a pathway for regulatory acceptance of dynamic tools for use in drug development programs.
What does fit for purpose mean pharmaceutical industry?
What is a fit for purpose model?
fit for purpose: a fit for purpose model is a model that generates the required results to the necessary level of accuracy within a manageable amount of time, i.e., it achieves its computational aim at a reasonable computational expense.
What is a product fit for purpose?
The ‘fit for purpose’ guarantee A supplier guarantees that goods will be reasonably fit for any purpose that the supplier or the consumer specified – the goods will do the job the consumer was told they would. This guarantee does not apply to goods bought at auction.